FindTrial
Sign In

A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19)

Clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030947
Enrollment
Unknown
Registered
2020-03-19
Start date
2020-02-11
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
38 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. patients who meet the requirements of the "diagnosis and treatment plan for pneumonia caused by novel coronavirus infection (the fourth edition)" issued by the general office of the national health commission; 2. patients with severe hypoxic respiratory failure treated with ECMO.

Exclusion criteria

Exclusion criteria: 1. aged >75 years old. 2. after cardiopulmonary resuscitation; 3. accompanied by other severe organ dysfunction (including severe liver and kidney dysfunction, massive upper gastrointestinal bleeding, DIC, etc.).

Design outcomes

Primary

MeasureTime frame
hospital mortality;—

Countries

China

Contacts

Public ContactZhaohui Tong

Beijing Chaoyang Hospital

tongzhaohuicy@sina.com+86 13910930309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026